Decibel Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Decibel Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2023.
  • Decibel Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2023 was -84 %, a 86.5% decline year-over-year.
  • Decibel Therapeutics, Inc. annual Return On Equity for 2022 was -60.2 %, a 87.5% decline from 2021.
  • Decibel Therapeutics, Inc. annual Return On Equity for 2021 was -32.1 %, a 197% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -84 -39 -86.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -69.2 -32.1 -86.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -60.2 -28.1 -87.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50.1 -3.99 -8.65% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.1 +70.4 +61% Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.1 -132 -139% Jan 1, 2022 Mar 31, 2022
Q4 2021 -32.1 -65.2 -197% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.2 Jul 1, 2021 Sep 30, 2021
Q2 2021 -115 Apr 1, 2021 Jun 30, 2021
Q1 2021 95 Jan 1, 2021 Mar 31, 2021
Q4 2020 33 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.